Suppr超能文献

阿尔茨海默病中氘代谢成像与氟代脱氧葡萄糖正电子发射断层显像的比较

Comparison of Deuterium Metabolic Imaging with FDG PET in Alzheimer Disease.

作者信息

Bøgh Nikolaj, Aastrup Malene, Mortensen Janne K, Gottrup Hanne, Blicher Jakob U, Borghammer Per, Kristensen Mattias H, Hansen Esben S S, Vaeggemose Michael, Laustsen Christoffer

机构信息

Department of Clinical Medicine, MR Research Centre, Aarhus University, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark.

Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.

出版信息

Radiology. 2025 Apr;315(1):e241808. doi: 10.1148/radiol.241808.

Abstract

Background The approval of amyloid-targeting therapies has made it increasingly important to differentiate Alzheimer disease (AD) from other causes of dementia. Dysfunctional glucose metabolism is a recognized pathophysiological element in AD that may be visualized with spectroscopic MRI of deuterated glucose and its metabolites, also known as deuterium metabolic imaging (DMI). Purpose To explore the potential of DMI as a diagnostic tool for AD. Materials and Methods In this prospective cross-sectional study, participants with newly diagnosed AD and age-matched controls were recruited from April to October 2023. DMI was performed with a 3-T system equipped with a proton/deuterium head coil following oral consumption of 75 g of deuterated glucose. Clinical fluorodeoxyglucose (FDG) PET data were acquired from patient records for comparison. The predefined primary outcome, the ratio between lactate and glutamine plus glutamate (Glx) at DMI, was analyzed using age-corrected linear mixed-effect models. Results Ten participants with AD (mean age, 72 years ± 6 [SD]; six women) and five age-matched healthy controls (mean age, 68 years ± 7; four men) were included. The primary analysis revealed no evidence of a difference in the ratio of lactate to Glx between participants with AD and controls ( = .24 across all regions of interest). Exploratory analyses revealed that participants with AD had reduced signals for medial temporal lactate (0.7 ± 0.2 vs 0.5 ± 0.1, = .04) and Glx (0.5 ± 0.03 vs 0.48 ± 0.05, = .03) compared with controls. Finally, a strong correlation ( = 0.73) was observed between DMI and FDG PET. Conclusion This study did not find evidence to support a shift from oxidative to anaerobic metabolism in AD. Exploratory analyses revealed a decrease in glucose metabolism in the medial temporal lobe. In extension hereof, a similar distribution of low DMI metabolism and decreased FDG PET glucose uptake was observed. © RSNA, 2025 See also the article by Liu et al in this issue. See also the editorial by Port in this issue.

摘要

背景

靶向淀粉样蛋白疗法的获批使得区分阿尔茨海默病(AD)与其他痴呆病因变得愈发重要。葡萄糖代谢功能障碍是AD中一种公认的病理生理因素,可通过氘代葡萄糖及其代谢物的磁共振波谱成像(也称为氘代谢成像,DMI)进行可视化。目的:探讨DMI作为AD诊断工具的潜力。材料与方法:在这项前瞻性横断面研究中,于2023年4月至10月招募了新诊断为AD的参与者和年龄匹配的对照组。在口服75 g氘代葡萄糖后,使用配备质子/氘头线圈的3-T系统进行DMI检查。从患者记录中获取临床氟代脱氧葡萄糖(FDG)PET数据以作比较。使用年龄校正的线性混合效应模型分析预定义的主要结局,即DMI时乳酸与谷氨酰胺加谷氨酸(Glx)的比值。结果:纳入了10名AD参与者(平均年龄,72岁±6[标准差];6名女性)和5名年龄匹配的健康对照者(平均年龄,68岁±7;4名男性)。初步分析显示,AD参与者与对照组之间乳酸与Glx的比值没有差异的证据(所有感兴趣区域的P值为0.24)。探索性分析显示,与对照组相比,AD参与者内侧颞叶的乳酸信号降低(0.7±0.2对0.5±0.1,P=0.04),Glx信号也降低(0.5±0.03对0.48±0.05,P=0.03)。最后,观察到DMI与FDG PET之间存在强相关性(r=0.73)。结论:本研究未发现支持AD中从氧化代谢向无氧代谢转变的证据。探索性分析显示内侧颞叶葡萄糖代谢降低。在此基础上,观察到低DMI代谢和FDG PET葡萄糖摄取降低的类似分布。©RSNA,2025 另见本期Liu等人的文章。另见本期Port的社论。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验